PCR66 Psychometric Validation of PROMIS-Fatigue-MS-8a Questionnaire in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2505
https://www.valueinhealthjournal.com/article/S1098-3015(23)05635-8/fulltext
Section Title :
Section Order :
11849
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05635-8&doi=10.1016/j.jval.2023.09.2505